109 Combined Modality Conference: "Metachronous urothelial carcinoma of the upper urinary tract after urothelial carcinoma of the bladder/ Adjuvant Hormonal Therapy in Male Breast Cancer" (052517)
The combined modality therapy approach, including the medical, surgical and radiation arms of cancer therapy, provides
the best treatment options for the management of a wide variety of cancer patients with complex problems. This course is
designed to educate an audience specializing in the care of cancer patients. This conference provides a forum for
multimodality interaction that promotes discussion of the most recent clinical research affecting patient care, as well as
bringing oncology specialists together to review cases and make recommendations for managing cancer patients.
Target Audience
Medical Radiation, and Surgical Oncologists; Radiologists; Pathologists; Urologists; Neurologists; UTSW Faculty, Fellows
and Residents in training; and private practice oncologists
Learning Objectives
At the conclusion of this activity, participants should be able to: (1) Review the management of a diversified group of
cancer patients through case presentations with pathologic and radiologic review and discussions by medical, radiation
and surgical oncologists; (2) Distinguish the importance of the interaction of surgical, medical and radiation modalities in
the treatment of these patients, and (3) Present the most recent advances in cancer therapy and basic cancer research
from a clinical and laboratory perspective, with an emphasis on new translational research approaches.
PRESENTER: Grace Raja, MD, Fellow
Hematology/Oncology
Topic: Assistance Programs for Oncology
Patients
PRESENTER: Bishoy Gayed, MD, Fellow
Urology
Topic: Comparative Functional Outcomes
between Open and Robotic
Prostatectomy
Jonathan Dowell, M.D., Moderator
Jonathan Dowell, M.D., Moderator
Available Credit
- 1.00 AMA
- 1.00 Attendance